Cargando…

Corrigendum to: A novel fully automated MRI-based deep-learning method for classification of 1p/19q co-deletion status in brain gliomas

Detalles Bibliográficos
Autores principales:	Yogananda, Chandan Ganesh Bangalore, Shah, Bhavya R, Yu, Frank F, Pinho, Marco C, Nalawade, Sahil S, Murugesan, Gowtham K, Wagner, Benjamin C, Mickey, Bruce, Patel, Toral R, Fei, Baowei, Madhuranthakam, Ananth J, Maldjian, Joseph A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830946/ https://www.ncbi.nlm.nih.gov/pubmed/36632567 http://dx.doi.org/10.1093/noajnl/vdac187

Ejemplares similares

A novel fully automated MRI-based deep-learning method for classification of 1p/19q co-deletion status in brain gliomas
por: Yogananda, Chandan Ganesh Bangalore, et al.
Publicado: (2021)

Errata: Brain tumor IDH, 1p/19q, and MGMT molecular classification using MRI-based deep learning: an initial study on the effect of motion and motion correction
por: Nalawade, Sahil S., et al.
Publicado: (2023)

A Fully Automated Deep Learning Network for Brain Tumor Segmentation
por: Bangalore Yogananda, Chandan Ganesh, et al.
Publicado: (2020)

MRI-Based Deep Learning Method for Classification of IDH Mutation Status
por: Bangalore Yogananda, Chandan Ganesh, et al.
Publicado: (2023)

Intrasession Reliability of Arterial Spin-Labeled MRI–Measured Noncontrast Perfusion in Glioblastoma at 3 T
por: Zhou, Limin, et al.
Publicado: (2020)

Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo
por: Rocha, C R R, et al.
Publicado: (2015)

Corrigendum to “Fully Covered Metallic Stents for the Treatment of Benign Airway Stenosis”
por: Dahlqvist, Caroline, et al.
Publicado: (2018)

In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs
por: Ashley, D M, et al.
Publicado: (2009)

Dysregulation of DGCR6 and DGCR6 L: psychopathological outcomes in chromosome 22q11.2 deletion syndrome
por: Chakraborty, D, et al.
Publicado: (2012)

Corrigendum to “Molecular Characterization of a Fully Human Chimeric T-Cell Antigen Receptor for Tumor-Associated Antigen EpCAM”
por: Shirasu, Naoto, et al.
Publicado: (2015)

[Corrigendum] Fully human VEGFR2 monoclonal antibody BC001 attenuates tumor angiogenesis and inhibits tumor growth
por: Xuan, Zi-Xue, et al.
Publicado: (2023)

Corrigendum to “Simulating Radiotherapy Effect in High-Grade Glioma by Using Diffusive Modeling and Brain Atlases”
por: Roniotis, Alexandros, et al.
Publicado: (2018)

Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy
por: Schmitz, M, et al.
Publicado: (2007)

Mesenchymal cell replacement corrects thymic hypoplasia in murine models of 22q11.2 deletion syndrome
por: Bhalla, Pratibha, et al.
Publicado: (2023)

Corrigendum to “Intraoperative Contrast Enhanced Ultrasound Evaluates the Grade of Glioma”
por: Cheng, Ling-Gang, et al.
Publicado: (2017)

CIRP Regulates BEV-Induced Cell Migration in Gliomas [Corrigendum]
Publicado: (2020)

Mobile phone use and risk of glioma in adults: case–control study
por: Milham, S
Publicado: (2006)

BCR‐ABL exon 7 deletion and novel point mutation in patient with chronic myelogenous leukemia
Publicado: (2019)

Corrigendum to “Deletion of Crry, the murine ortholog of the sporadic Alzheimer's disease risk gene CR1, impacts tau phosphorylation and brain CFH” [Neurosci. Lett. 533 (2013) 96–99]
por: Killick, R., et al.
Publicado: (2013)

Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma
por: Hottinger, A F, et al.
Publicado: (2018)

Knockdown of pseudogene DUXAP8 expression in glioma suppresses tumor cell proliferation
por: Zhao, Xu, et al.
Publicado: (2020)

Efficient isolation of targeted Caenorhabditis elegans deletion strains using highly thermostable restriction endonucleases and PCR
por: Wei, Aguan, et al.
Publicado: (2005)

Farnesoid X receptor deletion improves cardiac function, structure and remodeling following myocardial infarction in mice
por: Gao, Jianshu, et al.
Publicado: (2017)

Setting boundaries for genome-wide heterochromatic DNA deletions through flanking inverted repeats in Tetrahymena thermophile
por: Lin, Chih-Yi Gabriela, et al.
Publicado: (2019)

Jumonji AT-rich interactive domain 1B overexpression is associated with the development and progression of glioma
por: Fang, Liping, et al.
Publicado: (2016)

HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma
por: Qi, Yangzhi, et al.
Publicado: (2022)

Corrigendum to: Generation of immunocompetent syngeneic allograft mouse models for pediatric diffuse midline glioma
Publicado: (2023)

Corrigendum to “Chromosome 3p Inverted Duplication with Terminal Deletion: Second Postnatal Case Report with Additional Clinical Features”
por: Riley, Jacquelyn D., et al.
Publicado: (2019)

Corrigendum to: Generation of chromosome 1p/19q co-deletion by CRISPR/Cas9-guided genomic editing
Publicado: (2023)

Targeting EZH2 for glioma therapy with a novel nanoparticle–siRNA complex [Corrigendum]
Publicado: (2019)

Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response [Corrigendum]
Publicado: (2020)

Dihydroartemisinin inhibits the Raf/ERK/MEK and PI3K/AKT pathways in glioma cells
por: Du, Wei, et al.
Publicado: (2021)

Corrigendum to: Sex differences in the human reward system: convergent behavioral, autonomic and neural evidence
por: Warthen, Katherine G, et al.
Publicado: (2021)

Corrigendum: 1q21.1 deletion and a rare functional polymorphism in siblings with thrombocytopenia-absent radius–like phenotypes
por: Brodie, Seth A., et al.
Publicado: (2020)

Antitumor Effect of a New Nano-Vector with miRNA-135a on Malignant Glioma [Corrigendum]
Publicado: (2020)

SNHG15 affects the growth of glioma microvascular endothelial cells by negatively regulating miR-153
por: Ma, Yawen, et al.
Publicado: (2022)

Corrigendum to: Novel cancer gene discovery using a forward genetic screen in RCAS-PDGFB-driven gliomas
Publicado: (2023)

Corrigendum to “Interleukin-9 Deletion Relieves Vascular Dysfunction and Decreases Blood Pressure via the STAT3 Pathway in Angiotensin II-Treated Mice”
por: Yang, Yunzhao, et al.
Publicado: (2020)

MicroRNA-769-5p Promotes the Growth of Glioma Cells by Targeting Lysine Methyltransferase 2A [Corrigendum]
Publicado: (2021)

A Hybrid Glioma Tumor Cell Lysate Immunotherapy Vaccine Demonstrates Good Clinical Efficacy in the Rat Model [Corrigendum]
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1kj575dnicj3avtdajtrfb2jli